AnaptysBio, Inc. announced that Dr. Nicholas B. Lydon, Ph.D., FRS, a Class II director, will not stand for re-election at the Annual Meeting to be held on June 11, 2019. Accordingly, the company's nominating and corporate governance committee decided not to recommend that Dr. Lydon be nominated for re-election at the Annual Meeting, and its board of directors will decrease its size to six members effective as of the Annual Meeting.